Schrödinger to Present at Jefferies Global Biopharma Conference
Schrödinger (Nasdaq: SDGR) to participate in fireside chat at Jefferies Healthcare Conference on June 7, 2023.
05/26/2023 - 08:30 AM
NEW YORK --(BUSINESS WIRE)--
Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that management will participate in a fireside chat at the Jefferies Healthcare Conference. The live presentation will take place on Wednesday, June 7, 2023, at 2:30 p.m. ET.
The live discussion can be accessed under "News & Events" in the investors section of Schrödinger’s website, https://ir.schrodinger.com/news-and-events/event-calendar and will be archived for approximately seven days.
About Schrödinger
Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based computational platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is licensed by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger’s multidisciplinary drug discovery team also leverages the software platform to advance a portfolio of collaborative and proprietary programs to address unmet medical needs.
Founded in 1990, Schrödinger has approximately 800 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com , follow us on LinkedIn and Instagram , or visit our blog, Extrapolations.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20230526005008/en/
Allie Nicodemo
allie.nicodemo@schrodinger.com
Source: Schrödinger
Schrödinger will participate in a fireside chat at the Jefferies Healthcare Conference.
The live presentation will take place on Wednesday, June 7, 2023, at 2:30 p.m. ET.
The live discussion can be accessed under 'News & Events' in the investors section of Schrödinger’s website.
Yes, the discussion will be archived for approximately seven days.
SDGR Rankings
#2664 Ranked by Stock Gains
SDGR Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Technology Services, Packaged Software, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
US
City
New York
About SDGR
schrödinger is a leading provider of advanced molecular simulations and enterprise software solutions and services for pharmaceutical, biotechnology, and materials science research. the predictive power of schrödinger's software allows scientists to accelerate their research and development, reduce research costs, and make novel discoveries that might otherwise not be possible. schrödinger also establishes deep partnerships and collaborations with companies in such fields as biotechnology, pharmaceuticals, chemicals, and electronics, and helped found the biotech company nimbus therapeutics. through significant long-term investments in basic research, schrödinger has made scientific breakthroughs across many areas of drug discovery and materials science. hundreds of peer-reviewed scientific publications by schrödinger scientists are frequently among the most heavily cited in their fields. founded in 1990, schrödinger has operations in the us, europe, japan, and india, with business part
